What Happened
Greene Pharma LLC, doing business as Greene Medical Arts Pharmacy in Catskill, New York, agreed in June 2023 to pay $65,000 to resolve Controlled Substances Act allegations. A January 2022 DEA inspection found inadequate records of the receipt and disposition of controlled substances including oxycodone, hydrocodone, alprazolam, methylphenidate and buprenorphine. A self-audit could not account for 200 oxycodone tablets, 144 buprenorphine films and 2 buprenorphine tablets, which the pharmacy concluded were likely stolen by an inadequately screened employee. The pharmacy also agreed to a DEA Memorandum of Agreement requiring employee background checks and accurate records.
“agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.